(Q45863407)

17 December 2017

title

Development of adenovirus serotype 35 as a gene transfer vector (English)

1 reference

17 December 2017

1 reference

P Seshidhar Reddy

1

1 reference

17 December 2017

Shanthi Ganesh

2

1 reference

17 December 2017

M Paullin Limbach

3

1 reference

17 December 2017

Terrence Brann

4

1 reference

17 December 2017

Anne Pinkstaff

5

1 reference

17 December 2017

Michele Kaloss

6

1 reference

17 December 2017

Michael Kaleko

7

1 reference

17 December 2017

Sheila Connelly

8

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

17 December 2017

published in

Virology

1 reference

17 December 2017

volume

311

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

384-393

1 reference

17 December 2017

Blood clearance rates of adenovirus type 5 in mice

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Sequence of the immunoregulatory early region 3 and flanking sequences of adenovirus type 35.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Subgroup B adenovirus type 35 early region 3 mRNAs differ from those of the subgroup C adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Immune responses to adenovirus and adeno-associated virus in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Complement activation by recombinant adenoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Molecular epidemiology of adenovirus type 35 infections in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Fatal disseminated adenovirus infection in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Porcine adenovirus-3 as a helper-dependent expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Dependence of adenovirus infectivity on length of the fiber shaft domain

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Sequence and genetic organization of adenovirus type 35 early region 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Modification of protein synthesis initiation factors and the shut-off of host protein synthesis in adenovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Localization of the adenovirus early region 1B 55-kilodalton protein during lytic infection: association with nuclear viral inclusions requires the early region 4 34-kilodalton protein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

Circumvention of immunity to the adenovirus major coat protein hexon.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900161-2

7 January 2021

10.1016/S0042-6822(03)00161-2

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

12842627

1 reference

17 December 2017